Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders. - Pastor, Miryam; Fernández-Calle, Rosalía; Di Geronimo, Bruno; Vicente-Rodríguez, Marta; Zapico, José María; Gramage, Esther; Coderch, Claire; Pérez-García, Carmen; Lasek, Amy W.; Puchades-Carrasco, Leonor; Pineda-Lucena, Antonio; de Pascual-Teresa, Beatriz; et al. (European Journal of Medicinal Chemistry, 2018)